A recent article highlighted the utility of a panel that includes CA IX, CD10, AMACR, CK7, and CD117 if the differential diagnosis is limited to common primary renal tumors—such as clear cell RCC, papillary RCC, and chromophobe RCC [11]. The gene discussed is CA9; the disease is kidney neoplasm.